Pharmerit International

What Pharmerit International does

Pharmerit International is a private health economics and outcomes research (HEOR) and consulting firm founded in 2000 and headquartered in Berlin, Germany. The company delivers professional services to global pharmaceutical and biopharmaceutical clients, spanning health economics evidence generation, market access strategy, scientific and creative communications, and patient engagement. Its product pages and headcount disclosures are hosted under the affiliated OPEN Health platform (openhealthgroup.com), which reports approximately 1,100 employees globally and serves 200+ pharmaceutical clients; Pharmerit's own staff count is reported in the 101–250 range, suggesting it is a specialized subset or affiliate within that broader platform.

The firm's underlying capability is a professional-services platform combining deep scientific knowledge with specialist consulting expertise across the drug development lifecycle — from early development through market maturity — including a dedicated consulting sub-brand (Acsel Health) that markets strategic guidance, technical HEOR services, and bespoke patient solutions. Service revenue is generated primarily through long-cycle, project-based consulting engagements sold via a sales-led, enterprise field-motion to pharma and biotech clients; no productized pricing or self-serve offerings are disclosed. Customer engagements are structured as strategic partnerships rather than transactional deals, which implies multi-workstream relationships tied to evidence generation, reimbursement submissions, and ongoing medical communications.

The business model is classic professional services: revenue is earned from hourly/project fees on consulting and communications engagements, segmented heavily toward enterprise pharmaceutical and biopharmaceutical buyers. Marketing channels include industry events, website content and insights, news/publications, and client testimonials/cases — a mix consistent with enterprise consulting. There are no disclosed technology products, patents, or proprietary software platforms generating licensed or subscription revenue; competitive differentiation is asserted through a 20-year scientific-innovation track record, 47 industry awards since 2019, and the depth of expert talent — making this fundamentally a human-capital-driven consulting business rather than a technology or AI-native company.

Name

Pharmerit International

Website

https://pharmerit.com

Company type

Private

Founded year

2000

Headcount range

101–250 employees

Short description

Pharmerit International is a Berlin-based health economics and outcomes research (HEOR) and consulting firm serving 200+ global pharmaceutical clients with evidence generation, market access, scientific communications, and patient engagement services.

Ownership category

akta.pro rank

Product category

Health Economics and Outcomes Research (HEOR) Consulting

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Pricing & Contracting Strategy (HLAIAKAA)

akta.pro secondary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Health economics research
• Market access consulting
• Outcomes research services
• Medical communications
• Patient engagement solutions

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Professional Services Revenue: Revenue generated from providing consulting services including HEOR, market access, scientific communications, creative communications, and patient engagement to pharmaceutical clients

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pharmerit International provides health economics and outcomes research (HEOR), market access, scientific communications, creative communications, and patient engagement consulting services to global pharmaceutical and biotech clients. The firm combines deep scientific knowledge with specialist expertise to guide therapies from early development through market maturity, generating evidence to support reimbursement, regulatory, and commercial decision-making.

Product overview

OPEN Health is a flexible, global organization operating as a platform-plus-services model. The company provides integrated services across consulting (via Acsel Health), HEOR & market access, scientific communications, creative communications, and patient engagement. These offerings are designed to create high-performing strategic partnerships with pharmaceutical clients, uniting deep scientific knowledge with specialist expertise to deliver impact for patients and their families.

Differentiator

Problem solved

Functional benefit

Products and services

• Acsel Health Consulting

Quantifiable outcome

• 47 industry awards since 2019 recognizing work quality

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Parexel International: Large global CRO with significant real-world evidence, HEOR, and market access capabilities post its Strategic Partners and Health Advances units — competes for similar enterprise pharma engagements.
• Charles River Associates (Life Sciences practice): Global consulting firm with a life sciences practice covering HEOR, market access, pricing, and commercial strategy for pharma — competes with Pharmerit on strategic advisory mandates.
• Certara: Biosimulation and regulatory science company with a significant HEOR and market access consulting arm (formerly Analytica Laser), competing for pharma evidence-generation and pricing/reimbursement mandates.
• IQVIA: Largest global CRO and health data analytics provider with a significant HEOR, real-world evidence, and market access practice that competes with Pharmerit for the same enterprise pharma clients at a much larger scale.
• ICON plc: Global CRO that has built out HEOR and real-world evidence capabilities through acquisitions; competes with Pharmerit for enterprise pharma evidence-generation work as part of a broader clinical services portfolio.

Direct peers

• Evidera: Dedicated HEOR, market access, and real-world evidence consulting business (part of Thermo Fisher's PPD) that directly competes with Pharmerit across evidence generation, HTA submissions, and value communication for global pharma clients.
• RTI Health Solutions: Nonprofit-affiliated HEOR and market access consulting firm offering health economics, patient-centered outcomes research, and evidence synthesis — a closely comparable boutique competitor to Pharmerit.
• Avalere Health: Healthcare strategy consulting firm with deep HEOR, market access, and policy expertise serving biopharma — a closely comparable peer in evidence-based value strategy work.
• Precision Value & Health (Precision Medicine Group): Specialized HEOR, market access, and evidence commercialization consulting for biopharma — overlaps directly with Pharmerit's market access and value communication offerings.
• Trinity Life Sciences: Life sciences strategic consulting firm with strong HEOR, market access, and medical communications practices serving global pharma, directly overlapping Pharmerit's service portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/pharmerit
• Facebookfacebook.com/pharmerit-international-115867681795671
• LinkedInlinkedin.com/company/pharmerit

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmerit International